Skip to main content
Top
Published in: Pain and Therapy 2/2017

Open Access 01-12-2017 | Erratum

Erratum to: Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set

Authors: Neil K. Singla, Diana S. Meske, Paul J. Desjardins

Published in: Pain and Therapy | Issue 2/2017

Login to get access

Excerpt

The reference citations in Table 1 were published incorrectly in the original publication. The updated Table 1 is provided below:
Table 1
Description of studies included in analysis
https://static-content.springer.com/image/art%3A10.1007%2Fs40122-017-0078-1/MediaObjects/40122_2017_78_Taba_HTML.gif
Boxes highlighted in blue = no rescue; red = weak rescue; green = liberal rescue
APAP acetaminophen, HC hydrocodone, mg milligram, mm millimeter, NPRS numerical pain rating scale, OC oxycodone, VAS visual analog scale
aWeak rescue = APAP only; Liberal rescue = moderately potent short acting opioids, opioid/APAP combinations or non-steroidal anti-inflammatories
bNumber of patients randomized
cWhen multiple doses the value from the lowest overall daily dose is provided
Metadata
Title
Erratum to: Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set
Authors
Neil K. Singla
Diana S. Meske
Paul J. Desjardins
Publication date
01-12-2017
Publisher
Springer Healthcare
Published in
Pain and Therapy / Issue 2/2017
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-017-0078-1

Other articles of this Issue 2/2017

Pain and Therapy 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.